A phase II pilot study of combination of irinotecan and cisplatin in docetaxel/cisplatin-responsive advanced non-small cell lung cancer

Trial Profile

A phase II pilot study of combination of irinotecan and cisplatin in docetaxel/cisplatin-responsive advanced non-small cell lung cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 20 Sep 2007

At a glance

  • Drugs Cisplatin; Docetaxel; Irinotecan
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 20 Sep 2007 Last checked against ClinicalTrials.gov.
    • 11 Sep 2007 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 05 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top